Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim YH, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N.
Yamauchi I, et al. Among authors: fujii t.
PLoS One. 2019 May 14;14(5):e0216954. doi: 10.1371/journal.pone.0216954. eCollection 2019.
PLoS One. 2019.
PMID: 31086392
Free PMC article.